US › Healthcare

Marpai Inc (MRAI)

US · Healthcare · Healthcare Plans

$2.20+2.80%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$4.4M

Revenue YoY

-18.0%

Net profit

$-3.2M

Profit YoY

-3.7%

EPS

$-0.20

EPS estimate

$-0.10

Net margin

-71.6%

EPS came in at -0.20 against a street estimate of -0.10 — a miss of 100.0%.

Key statistics

Market cap

$56.4M

Forward P/E

0.0

P/B

1.49

Book value

$-1.39

EPS (TTM)

$-24.12

52-week high

$2.50

52-week low

$0.21

50-day MA

$0.96

200-day MA

$0.74

Beta

4.90

Analyst view

Analysts rate Marpai Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $6.00.

Shareholding

Insiders

48.22%

Institutions

3.83%

Largest institutional holders

Fund	Stake
FNY Investment Advisers, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Marpai Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.